Home / Compliance actions / 628646

FDA Warning Letter — VAPE CRUSADERS PREMIUM E-LIQUID

Case 628646 — FEI 3013454434

The FDA took a Warning Letter action against VAPE CRUSADERS PREMIUM E-LIQUID on Mar 10, 2022 (Roseburg, OR). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
VAPE CRUSADERS PREMIUM E-LIQUID
Date
Mar 10, 2022
Fiscal Year
2022
Product Type
Tobacco
Center
CTP
Location
Roseburg, OR (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.